New Drug Labeling Format Encourages Physician-Patient Interaction
Executive Summary
FDA's final labeling rule creates several new sections designed to facilitate physicians' drug prescribing practices
You may also be interested in...
Patient Counseling Section Of Labeling Should Be Limited, FDA Advises
Only the most important, not necessarily the most common, side effects should be included in the section denoting what a health care provider should tell a patient, FDA’s draft guidance says; section was mandated under 2006 physician labeling rule.
Allergan Bats Its Eyes At Consumers With Latisse Marketing Campaign
Allergan is charting new territory in marketing its eyelash growth stimulant Latisse, a product with a purely aesthetic indication that will be uniquely consumer-driven
Allergan Bats Its Eyes At Consumers With Latisse Marketing Campaign
Allergan is charting new territory in marketing its eyelash growth stimulant Latisse, a product with a purely aesthetic indication that will be uniquely consumer-driven